Clinical Trial Update: Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how Rifampin affects the pharmacokinetics of romidepsin in patients with advanced cancer, completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Lymphoma

Drugs mentioned

• RIFAMPIN (RIFAMPIN)
• Romidepsin (romidepsin)

Snippet

Sponsor: Celgene | Conditions: Hematologic Malignancy, Malignant Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2013-05-13